Pharmacological characterization of a novel metal-based proteasome inhibitor Na-AuPT for cancer treatment.

MLA

Xu, Da-Cai, et al. “Pharmacological Characterization of a Novel Metal-Based Proteasome Inhibitor Na-AuPT for Cancer Treatment.” Acta Pharmacologica Sinica, vol. 43, no. 8, Aug. 2022, pp. 2128–38. EBSCOhost, https://doi.org/10.1038/s41401-021-00816-z.

APA

Xu, D.-C., Yang, L., Zhang, P.-Q., Yan, D., Xue, Q., Huang, Q.-T., Li, X.-F., Hao, Y.-L., Tang, D.-L., Ping Dou, Q., Chen, X., & Liu, J.-B. (2022). Pharmacological characterization of a novel metal-based proteasome inhibitor Na-AuPT for cancer treatment. Acta Pharmacologica Sinica, 43(8), 2128–2138. https://doi.org/10.1038/s41401-021-00816-z

Chicago

Xu, Da-Cai, Li Yang, Pei-Quan Zhang, Ding Yan, Qian Xue, Qing-Tian Huang, Xiao-Fen Li, et al. 2022. “Pharmacological Characterization of a Novel Metal-Based Proteasome Inhibitor Na-AuPT for Cancer Treatment.” Acta Pharmacologica Sinica 43 (8): 2128–38. doi:10.1038/s41401-021-00816-z.